The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Ethel S. Siris

Toni Stabile Osteoporosis Center and Metabolic Bone Diseases Program

Division of Endocrinology

Department of Medicine

Columbia University Medical Center

USA

[email]@columbia.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Toni Stabile Osteoporosis Center and Metabolic Bone Diseases Program, Division of Endocrinology, Department of Medicine, Columbia University Medical Center, USA. 2001 - 2012
  • College of Physicians and Surgeons, Columbia University, New York, USA. 2002 - 2006

References

  1. What's in a name? What constitutes the clinical diagnosis of osteoporosis? Siris, E.S., Boonen, S., Mitchell, P.J., Bilezikian, J., Silverman, S. Osteoporos. Int (2012) [Pubmed]
  2. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. Siris, E.S., Baim, S., Nattiv, A. Postgrad. Med (2010) [Pubmed]
  3. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Siris, E.S., Selby, P.L., Saag, K.G., Borgström, F., Herings, R.M., Silverman, S.L. Am. J. Med. (2009) [Pubmed]
  4. Effects of risedronate on fracture risk in postmenopausal women with osteopenia. Siris, E.S., Simon, J.A., Barton, I.P., McClung, M.R., Grauer, A. Osteoporos. Int (2008) [Pubmed]
  5. Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Siris, E.S., Genant, H.K., Laster, A.J., Chen, P., Misurski, D.A., Krege, J.H. Osteoporos. Int (2007) [Pubmed]
  6. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Siris, E.S., Brenneman, S.K., Barrett-Connor, E., Miller, P.D., Sajjan, S., Berger, M.L., Chen, Y.T. Osteoporos. Int (2006) [Pubmed]
  7. Patients with hip fracture: what can be improved?. Siris, E.S. Bone (2006) [Pubmed]
  8. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Siris, E.S., Harris, S.T., Rosen, C.J., Barr, C.E., Arvesen, J.N., Abbott, T.A., Silverman, S. Mayo Clin. Proc. (2006) [Pubmed]
  9. Medical management of Paget's disease of bone: indications for treatment and review of current therapies. Siris, E.S., Lyles, K.W., Singer, F.R., Meunier, P.J. J. Bone Miner. Res. (2006) [Pubmed]
  10. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study. Siris, E.S., Harris, S.T., Eastell, R., Zanchetta, J.R., Goemaere, S., Diez-Perez, A., Stock, J.L., Song, J., Qu, Y., Kulkarni, P.M., Siddhanti, S.R., Wong, M., Cummings, S.R. J. Bone Miner. Res. (2005) [Pubmed]
  11. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Siris, E.S., Chen, Y.T., Abbott, T.A., Barrett-Connor, E., Miller, P.D., Wehren, L.E., Berger, M.L. Arch. Intern. Med. (2004) [Pubmed]
  12. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA). Siris, E.S., Brenneman, S.K., Miller, P.D., Barrett-Connor, E., Chen, Y.T., Sherwood, L.M., Abbott, T.A. J. Bone Miner. Res. (2004) [Pubmed]
  13. Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. Siris, E.S., Bilezikian, J.P., Rubin, M.R., Black, D.M., Bockman, R.S., Bone, H.G., Hochberg, M.C., McClung, M.R., Schnitzer, T.J. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  14. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation. Siris, E., Adachi, J.D., Lu, Y., Fuerst, T., Crans, G.G., Wong, M., Harper, K.D., Genant, H.K. Osteoporos. Int (2002) [Pubmed]
  15. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. Siris, E.S., Miller, P.D., Barrett-Connor, E., Faulkner, K.G., Wehren, L.E., Abbott, T.A., Berger, M.L., Santora, A.C., Sherwood, L.M. JAMA (2001) [Pubmed]
 
WikiGenes - Universities